Daryl K. Granner, MD, Named American Diabetes Association’s 2017 Albert Renold Award Recipient
May 10, 2017
Daryl K. Granner, MD, has been selected to receive the American Diabetes Association® (Association) 2017 Albert Renold Award. This award recognizes an individual whose career is distinguished by outstanding achievements in the training and mentorship of diabetes research scientists and in the facilitation of diabetes research. Dr. Granner will be recognized with this honor during the Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center.
Dr. Granner, who is currently Professor Emeritus of Molecular Physiology and Biophysics at Vanderbilt University, and Professor Emeritus of Molecular Physiology and Biophysics and of Internal Medicine at the University of Iowa, has had a lifelong commitment to both diabetes-related research and to training the next generation of diabetes scientists.
“Dr. Granner’s contributions to the mentorship and the development of future diabetes researchers has helped to ensure that bright young minds will continue to make headway in improving the lives of people with diabetes,” said the Association’s President of Medicine and Science Alvin C. Powers, MD “Congratulations on this tremendous honor, and thank you for your many vital contributions to our field.”
With a renowned research program investigating the hormonal regulation of gene expression, Dr. Granner’s laboratory made significant contributions to our understanding of how insulin regulates glucose metabolism. Many of his trainees have become tenured faculty members and researchers in diabetes and metabolism.
Beyond his own laboratory, Dr. Granner founded and directed two NIH-sponsored training programs in molecular endocrinology – one at the University of Iowa and one at Vanderbilt University. Combined, these two programs have trained more than 120 students and fellows. Furthermore, Dr. Granner led the Vanderbilt Medical Scientist Training Program for MD, PhD students, which tripled in size under his leadership. He also established an NIH-supported Diabetes Endocrinology Research Center at Iowa and more recently, their Fraternal Order of Eagles Diabetes Research Center. At Vanderbilt, he consolidated several entities into the Comprehensive Vanderbilt Diabetes Center and was one of the founders a first-of-its-kind mouse metabolic phenotyping core. These programs and resources have expanded the reach of diabetes research and care around the globe.
The 2017 Albert Renold Award is supported by an unrestricted grant from Merck.
The American Diabetes Association’s 77th Scientific Sessions, to be held June 9-13, 2017, at the San Diego Convention Center, is the world’s largest scientific meeting focused on diabetes research, prevention and care. During the five-day meeting, health care professionals have exclusive access to more than 2,500 original research presentations, participate in provocative and engaging exchanges with leading diabetes experts, and can earn Continuing Medical Education (CME) or Continuing Education (CE) credits for educational sessions. The program is grouped into eight interest areas: Acute and Chronic Complications; Behavioral Medicine, Clinical Nutrition, Education and Exercise; Clinical Diabetes/Therapeutics; Epidemiology/Genetics; Immunology/Transplantation; Insulin Action/Molecular Metabolism; Integrated Physiology/Obesity; and Islet Biology/Insulin Secretion. Brenda Montgomery, RN, MSHS, CDE, President of Health Care and Education¹, will deliver her address on Saturday, June 10, and Alvin C. Powers, MD, President of Medicine and Science, will present his address on Sunday, June 11. Eight abstracts were selected by the Scientific Sessions Meeting Planning Committee to be presented on Tuesday, June 13, in the President’s Oral Session. These abstracts represent important research being conducted in the field of diabetes today. In total, the 2017 Scientific Sessions includes 378 abstracts in 49 oral sessions; 2,152 poster presentations including 50 moderated poster discussions; and 360 published-only abstracts.
About the American Diabetes Association
Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)
1 Disclosures for Brenda Montgomery. Employer: AstraZeneca Pharmaceuticals. Montgomery's role as President, Health Care & Education of the American Diabetes Association (Association) is a voluntary position to which she was elected by the members of the Association in 2015. She continues to recuse herself from any and all discussions, decisions or votes that have or could be perceived as having a conflict of interest with her employer.